About Kent Payne
Kent Payne is a director at Goodwin Biotechnology.
Kent Payne first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Kent Payne in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kent Payne works with at each company, as listed on that company's latest Form D.
Goodwin Biotechnology, Inc · Form D, Jan 27, 2026
KP
Karl Pinto
Chief Executive Officer and director
NP
Nikhil Puri
Director
BP
Brandon Price
Director
DM
Divya Menezes
Director
SV
Steven Vorgity
Executive officer